ICU MEDICAL INC (ICUI) Fundamental Analysis & Valuation

NASDAQ:ICUI • US44930G1076

Current stock price

117.715 USD
+2.27 (+1.96%)
Last:

This ICUI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ICUI Profitability Analysis

1.1 Basic Checks

  • In the past year ICUI was profitable.
  • In the past year ICUI had a positive cash flow from operations.
  • In multiple years ICUI reported negative net income over the last 5 years.
  • Of the past 5 years ICUI 4 years had a positive operating cash flow.
ICUI Yearly Net Income VS EBIT VS OCF VS FCFICUI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • With a decent Return On Assets value of 0.02%, ICUI is doing good in the industry, outperforming 71.12% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 0.03%, ICUI is in the better half of the industry, outperforming 71.66% of the companies in the same industry.
  • ICUI's Return On Invested Capital of 2.43% is fine compared to the rest of the industry. ICUI outperforms 70.59% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 9.12%.
  • The 3 year average ROIC (1.99%) for ICUI is below the current ROIC(2.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROIC 2.43%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ICUI Yearly ROA, ROE, ROICICUI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • The Profit Margin of ICUI (0.03%) is better than 71.66% of its industry peers.
  • ICUI's Profit Margin has declined in the last couple of years.
  • ICUI's Operating Margin of 4.90% is fine compared to the rest of the industry. ICUI outperforms 70.59% of its industry peers.
  • In the last couple of years the Operating Margin of ICUI has declined.
  • ICUI's Gross Margin of 36.84% is on the low side compared to the rest of the industry. ICUI is outperformed by 71.12% of its industry peers.
  • ICUI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
ICUI Yearly Profit, Operating, Gross MarginsICUI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ICUI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
  • Compared to 1 year ago, ICUI has more shares outstanding
  • Compared to 5 years ago, ICUI has more shares outstanding
  • ICUI has a better debt/assets ratio than last year.
ICUI Yearly Shares OutstandingICUI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ICUI Yearly Total Debt VS Total AssetsICUI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 1.98 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ICUI's Altman-Z score of 1.98 is fine compared to the rest of the industry. ICUI outperforms 60.43% of its industry peers.
  • ICUI has a debt to FCF ratio of 15.58. This is a negative value and a sign of low solvency as ICUI would need 15.58 years to pay back of all of its debts.
  • ICUI has a better Debt to FCF ratio (15.58) than 69.52% of its industry peers.
  • A Debt/Equity ratio of 0.60 indicates that ICUI is somewhat dependend on debt financing.
  • ICUI has a Debt to Equity ratio of 0.60. This is in the lower half of the industry: ICUI underperforms 64.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Altman-Z 1.98
ROIC/WACC0.32
WACC7.58%
ICUI Yearly LT Debt VS Equity VS FCFICUI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that ICUI has no problem at all paying its short term obligations.
  • ICUI has a Current ratio (2.39) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.15 indicates that ICUI should not have too much problems paying its short term obligations.
  • ICUI's Quick ratio of 1.15 is on the low side compared to the rest of the industry. ICUI is outperformed by 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.15
ICUI Yearly Current Assets VS Current LiabilitesICUI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ICUI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.76% over the past year.
  • The Earnings Per Share has been growing slightly by 1.71% on average over the past years.
  • ICUI shows a decrease in Revenue. In the last year, the revenue decreased by -6.33%.
  • The Revenue has been growing by 11.91% on average over the past years. This is quite good.
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.23% on average over the next years. This is quite good.
  • Based on estimates for the next years, ICUI will show a small growth in Revenue. The Revenue will grow by 4.49% on average per year.
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ICUI Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.17 indicates a correct valuation of ICUI.
  • 85.03% of the companies in the same industry are more expensive than ICUI, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ICUI to the average of the S&P500 Index (26.54), we can say ICUI is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 14.23, ICUI is valued correctly.
  • 87.70% of the companies in the same industry are more expensive than ICUI, based on the Price/Forward Earnings ratio.
  • ICUI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.68.
Industry RankSector Rank
PE 15.17
Fwd PE 14.23
ICUI Price Earnings VS Forward Price EarningsICUI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaply inside the industry as 85.03% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than the industry average as 74.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 35.51
EV/EBITDA 12.47
ICUI Per share dataICUI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.29
PEG (5Y)8.88
EPS Next 2Y9.98%
EPS Next 3Y9.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ICUI Dividend Analysis

5.1 Amount

  • ICUI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICUI Fundamentals: All Metrics, Ratios and Statistics

ICU MEDICAL INC

NASDAQ:ICUI (4/30/2026, 12:35:10 PM)

117.715

+2.27 (+1.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength15.53
Industry Growth33.54
Earnings (Last)02-19
Earnings (Next)05-07
Inst Owners116.12%
Inst Owner Change-0.04%
Ins Owners1.93%
Ins Owner Change7.01%
Market Cap2.94B
Revenue(TTM)2.23B
Net Income(TTM)732.00K
Analysts83.33
Price Target187.27 (59.09%)
Short Float %5.41%
Short Ratio4.44
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.77%
Min EPS beat(2)10.68%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)29.63%
Min EPS beat(4)10.68%
Max EPS beat(4)38.85%
EPS beat(8)8
Avg EPS beat(8)31.35%
EPS beat(12)12
Avg EPS beat(12)27.15%
EPS beat(16)15
Avg EPS beat(16)20.28%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)2.43%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)0.8%
Revenue beat(12)6
Avg Revenue beat(12)-0.83%
Revenue beat(16)7
Avg Revenue beat(16)-0.86%
PT rev (1m)0%
PT rev (3m)1.21%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)-1.98%
EPS NY rev (1m)0%
EPS NY rev (3m)0.87%
Revenue NQ rev (1m)-0.35%
Revenue NQ rev (3m)-0.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 15.17
Fwd PE 14.23
P/S 1.32
P/FCF 35.51
P/OCF 16.36
P/B 1.39
P/tB N/A
EV/EBITDA 12.47
EPS(TTM)7.76
EY6.59%
EPS(NY)8.27
Fwd EY7.03%
FCF(TTM)3.31
FCFY2.82%
OCF(TTM)7.2
OCFY6.11%
SpS89.29
BVpS84.99
TBVpS-0.38
PEG (NY)2.29
PEG (5Y)8.88
Graham Number121.814 (3.48%)
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.03%
ROCE 3.08%
ROIC 2.43%
ROICexc 2.66%
ROICexgc 7.78%
OM 4.9%
PM (TTM) 0.03%
GM 36.84%
FCFM 3.71%
ROA(3y)-1.15%
ROA(5y)0.08%
ROE(3y)-2.45%
ROE(5y)-0.91%
ROIC(3y)1.99%
ROIC(5y)2.63%
ROICexc(3y)2.16%
ROICexc(5y)3.42%
ROICexgc(3y)6.21%
ROICexgc(5y)6.59%
ROCE(3y)2.51%
ROCE(5y)3.33%
ROICexgc growth 3Y68.14%
ROICexgc growth 5Y-6.18%
ROICexc growth 3Y65.14%
ROICexc growth 5Y-20.85%
OM growth 3Y57.68%
OM growth 5Y-13.09%
PM growth 3YN/A
PM growth 5Y-65.63%
GM growth 3Y6.38%
GM growth 5Y0.29%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 15.58
Debt/EBITDA 4.09
Cap/Depr 48.33%
Cap/Sales 4.35%
Interest Coverage 1.31
Cash Conversion 58%
Profit Quality 11315.8%
Current Ratio 2.39
Quick Ratio 1.15
Altman-Z 1.98
F-Score6
WACC7.58%
ROIC/WACC0.32
Cap/Depr(3y)43.46%
Cap/Depr(5y)52.62%
Cap/Sales(3y)4.09%
Cap/Sales(5y)4.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.76%
EPS 3Y5.87%
EPS 5Y1.71%
EPS Q2Q%-9.48%
EPS Next Y6.62%
EPS Next 2Y9.98%
EPS Next 3Y9.85%
EPS Next 5Y9.23%
Revenue 1Y (TTM)-6.33%
Revenue growth 3Y-0.72%
Revenue growth 5Y11.91%
Sales Q2Q%-13.78%
Revenue Next Year-1.33%
Revenue Next 2Y1.52%
Revenue Next 3Y3.23%
Revenue Next 5Y4.49%
EBIT growth 1Y6.35%
EBIT growth 3Y56.54%
EBIT growth 5Y-2.74%
EBIT Next Year28.75%
EBIT Next 3Y15.51%
EBIT Next 5Y12.24%
FCF growth 1Y-27.23%
FCF growth 3YN/A
FCF growth 5Y-7.51%
OCF growth 1Y-11.85%
OCF growth 3YN/A
OCF growth 5Y-4.19%

ICU MEDICAL INC / ICUI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICUI.


Can you provide the valuation status for ICU MEDICAL INC?

ChartMill assigns a valuation rating of 5 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.


Can you provide the profitability details for ICU MEDICAL INC?

ICU MEDICAL INC (ICUI) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for ICUI stock?

The Price/Earnings (PE) ratio for ICU MEDICAL INC (ICUI) is 15.17 and the Price/Book (PB) ratio is 1.39.


What is the earnings growth outlook for ICU MEDICAL INC?

The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 6.62% in the next year.